SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950135-05-002549
Filing Date
2005-05-05
Accepted
2005-05-05 09:58:27
Documents
2
Effectiveness Date
2005-05-05

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b55019dfdefa14a.htm DEFA14A 11896
2 EX-99.1 PRESS RELEASE DATED MAY 5, 2005 b55019dfexv99w1.htm EX-99.1 33672
  Complete submission text file 0000950135-05-002549.txt   46869
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-21481 | Film No.: 05801622
SIC: 2836 Biological Products, (No Diagnostic Substances)